Announcements

Job offersmore »

Tweeting Growers

Top 5 - yesterday

Top 5 - last week

Top 5 - last month

Exchange ratesmore »




US: Cannabis Science CEO to speak at Harvard Medical School

Cannabis Science's President, CEO and Co-Founder, Raymond C. Dabney, will be a keynote speaker and panelist at the Global Health Catalyst (GHC) Summit at Harvard Medical School on April 28-30, 2017. Additionally, Cannabis Science's Chief Medical Officer (CMO), Allen Herman, will Co-Chair a special session at the GHC Summit. Both Dabney and Herman previously presented at Harvard Medical School in November 2016.

Dabney will be the keynote speaker and a panelist for a special session on "Cannabis Science Versus Cancer and Other Malignancies." Dabney will discuss how cannabinoids can be used to treat cancer and other diseases, manage the side effects of cancer treatment like radiotherapy and chemotherapy, and potential applications of medical cannabis in global health to close the global pain divide; Cannabis Science's vision for the global health and development impact of cannabinoid-based medicines; and the need for greater public education on the importance of medical cannabis research.

Additionally, Dabney will present summit participants with an overview of the company's current drug development program, as well as with an update on Cannabis Science's Collaborative Research Agreement (CRA) with Dana-Farber Cancer Institute (Dana-Farber). In addition to co-chairing the session, Herman will participate in the discussion on the epidemiology of cancer and the utilization of opioids in Africa as opioid utilization rates reflect the pain divide. This conference affords Cannabis Science an opportunity to discuss cutting-edge cannabinoid research with some of the greatest minds in modern medicine globally, as well as to network and explore potential partnerships. In addition, through participation in this Summit, Cannabis Science will give updates on progress in the implementation of Cannabis Science's research agreement with Dana-Farber and a potential consortium agreement involving other institutions.

On January 3, 2017, Cannabis Science entered into a CRA with Dana-Farber, one of the world's leading cancer centers. Under the terms of the CRA, Cannabis Science and Dana-Farber will jointly investigate and develop use of cannabinoids to treat various forms of cancers.

"I am excited about Cannabis Science's relationship with Dana-Farber. When I first met Wilfred Ngwa, PhD, Director of Global Health Catalyst at Harvard Medical School and Principal Investigator for the CRA, we immediately realized potential synergies on cancer research interests, and the potential to collaborate to develop cannabinoid-based medicines to treat cancer and control cancer symptoms with minimal side-effects," stated Dabney.

Dabney and Ngwa met during the Constituency for Africa's (CFA) annual Ronald H. Brown African Affairs Series in Washington, DC in September 2016, where they both were on the speaking program. Mr. Dabney is a Member of the Board of Directors of CFA, and the Vice Chairman of CFA's African Healthcare Infrastructure Committee (AHIC).

For more information:
www.globalhealthcatalystsummit.org
cannabisscience.com

Publication date: 3/8/2017

 


 

Other news in this sector:

3/28/2017 Israel looks to leverage tech in lucrative MMJ market
3/27/2017 US (LA): LSU extends deadline for MMJ business proposals
3/23/2017 US: Pineapple Express denies it's being sued
3/23/2017 US (CA): Production permit for Marijuana Company of America
3/22/2017 US: Pineapple Express sued over $685K in unpaid bills
3/22/2017 US (PA): Zoning permissions for MMJ sites in Philadelphia
3/22/2017 US (AR): Senate passes several medical marijuana bills
3/21/2017 US (OH): Eastlake approves medical marijuana greenhouse
3/21/2017 Fertilizer manufacturer sees revenues grow thanks to cannabis
3/20/2017 US (OH): Large MMJ growth facility planned in Wilmington
3/20/2017 What will more regulation mean for MMJ growers?
3/17/2017 Canada: Third lawsuit over tainted MMJ
3/17/2017 MMJ permits for 37 Israeli growers
3/16/2017 Oxford University launches MMJ research programme
3/16/2017 MMJ outlets linked to organized crime, Toronto police say
3/15/2017 Silicon Valley hosts cannabis investor conference
3/14/2017 Colombia's MMJ industry takes shape
3/14/2017 How to size a cooling system for your indoor garden
3/14/2017 Philippines considers legalizing medical marijuana
3/14/2017 LED supplier expands team with North American cannabis expert